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Background: Beckwith-Wiedemann syndrome (BWS) is a loss-of-imprinting pediatric overgrowth syndrome. The
primary features of BWS include macrosomia, macroglossia, and abdominal wall defects. Secondary features that are
frequently observed in BWS patients are hypoglycemia, nevus flammeus, polyhydramnios, visceromegaly,
hemihyperplasia, cardiac malformations, and difficulty breathing. BWS is speculated to occur primarily as the result
of the misregulation of imprinted genes associated with two clusters on chromosome 11p15.5, namely the KvDMR1
and H19/IGF2. A similar overgrowth phenotype is observed in bovine and ovine as a result of embryo culture. In
ruminants this syndrome is known as large offspring syndrome (LOS). The phenotypes associated with LOS are
increased birth weight, visceromegaly, skeletal defects, hypoglycemia, polyhydramnios, and breathing difficulties.
Even though phenotypic similarities exist between the two syndromes, whether the two syndromes are
epigenetically similar is unknown. In this study we use control Bos taurus indicus X Bos taurus taurus F1 hybrid
bovine concepti to characterize baseline imprinted gene expression and DNA methylation status of imprinted
domains known to be misregulated in BWS. This work is intended to be the first step in a series of experiments
aimed at determining if LOS will serve as an appropriate animal model to study BWS.
Results: The use of F1 B. t. indicus x B. t. taurus tissues provided us with a tool to unequivocally determine
imprinted status of the regions of interest in our study. We found that imprinting is conserved between the bovine
and human in imprinted genes known to be associated with BWS. KCNQ1OT1 and PLAGL1 were
paternally-expressed while CDKN1C and H19 were maternally-expressed in B. t. indicus x B. t. taurus F1 concepti. We
also show that in bovids, differential methylation exists at the KvDMR1 and H19/IGF2 ICRs.
Conclusions: Based on these findings we conclude that the imprinted gene expression of KCNQ1OT1, CDKN1C, H19,
and PLAGL1 and the methylation patterns at the KvDMR1 and H19/IGF2 ICRs are conserved between human and
bovine. Future work will determine if LOS is associated with misregulation at these imprinted loci, similarly to what
has been observed for BWS.
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Genomic imprinting is an epigenetic modification that
directs parent-specific gene expression. Imprinted genes
are responsible for regulating growth and development
of the conceptus [1]. These genes are typically found in
clusters containing both maternally- and paternally-
expressed genes. The correct allelic expression of the
clustered genes is regulated by a neighboring region of
DNA which is differentially methylated and is known as
the imprinting control region (ICR; [2-4]). The effect of
the ICR on a cluster of imprinted genes can span for
megabases in a bidirectional manner [5].
Imprinted genes are functionally haploid [6] and there-
fore are vulnerable to epigenetic mutations and loss-of-
imprinting (LOI; [7]). LOI refers to the misregulation of
imprinted gene expression which results in either loss of
expression or biallelic expression of these genes.
There are several LOI disorders in humans including
Beckwith-Wiedemann syndrome (BWS), Angelman syn-
drome, Prader-Willi syndrome, and Silver Russell syn-
drome. BWS is the most frequent LOI syndrome
observed in humans with an incidence of one in 13,700
live births [8,9]. BWS is also the most common pediatric
overgrowth syndrome [9]. The overgrowth parameters
for height and weight for BWS patients are among the
97th percentile [9].
The primary features of BWS include macroglossia,
macrosomia, and abdominal wall defects [10,11]. The sec-
ondary features include visceromegaly, polyhydramnios,
renal abnormalities, facial nevus flammeus, hypoglycemia,
hemihyperplasia, ear creases and helical pits, and cardiac
malformations [9-12]. Children with this syndrome also
have an increased susceptibility (4–21%) to develop em-
bryonic tumors by the time they turn five years of age
[8,13,14]. Wilms’ tumor of the kidney is the most com-
mon embryonic tumor (67% of cases) observed in BWS
patients [14].
BWS is thought to occur because of the dysregulation of
several imprinted genes located primarily on chromosome
11p15.5 [9,11,15]. The two main imprinted gene clusters
associated with BWS are those directed by the KvDMR1
and H19/IGF2 ICRs [12,16]. The BWS-associated
imprinted genes regulated by the KvDMR1 include the
paternally-expressed non-coding RNA KCNQ1OT1 and
the maternally expressed coding genes CDKN1C, KCNQ1,
and PHLDA2. In mice, expression of CDKN1C is also
regulated by a differentially-methylated region (DMR) of
DNA that encompasses the promoter and extends
through exon 2 [17,18]. Contrary to what has been
reported for mice, no differential methylation is observed
for CDKN1C in humans [19].
The KvDMR1 is methylated on the maternal allele and
unmethylated on the paternal allele in mouse and
human. Loss of methylation (LOM) at the KvDMR1 onthe maternal allele is the most common epigenetic de-
fect (50%) observed in BWS patients [9,12,16,20,21].
This LOM results in the aberrant expression of the long
noncoding RNA (ncRNA) KCNQ1OT1 from the mater-
nal allele which results in bidirectional silencing of the
maternally-expressed flanking genes, in particular
CDKN1C [8,22].
The H19/IGF2 ICR regulates the expression of the
paternally-expressed gene IGF2 and the maternally-
expressed ncRNA H19. This region is unmethylated on
the maternal allele and methylated on the paternal
allele [12]. The gain of methylation on the maternal allele
results in the repression of H19 from the maternal allele
leading to biallelic expression of IGF2. This epimutation
occurs in 2–10% of BWS patients and is highly associated
with tumor development [9,16,23]. Recent studies have
found that some BWS patients also have LOM at the
HYMAI/PLAGL1, MEST, and GRB10 ICRs [24-26].
In humans PLAGL1 is found on chromosome six, unlike
the other genes associated with BWS which are found pri-
marily on chromosome 11. PLAGL1 functions as a tumor
suppressor and can induce apoptosis [27,28]. In a study by
Arima et al., [27] it was determined that PLAGL1 is
expressed similarly to CDKN1C in many tissues. A recent
microarray study [29] places PLAGL1 as a pivotal player
in the regulation of expression of a network of imprinted
genes, including H19, IGF2, and CDKN1C.
In ruminants there is an overgrowth syndrome that
resembles BWS. The overgrowth syndrome in ruminants
is known as large offspring syndrome (LOS; [30]). LOS
has been documented to result from several embryo cul-
ture conditions [31-34] and high protein diet supple-
mentation to the dam prior to conception and during
early pregnancy [35]. The phenotypical features of LOS
include: increased birth weight, macrosomia, skeletal
defects, hypoglycemia, polyhydramnios, visceromegaly,
difficulty suckling, and perinatal death [30,31,36-38].
Currently, no animal models exist that recapitulate the
overgrowth phenotype of BWS. Murine knockout mod-
els for BWS have been unable to display all the primary
features observed in children with BWS [39]. As an ef-
fort to develop treatments for BWS symptoms, our
long-term goal is to determine if LOS in ruminants can
be used as an animal model to understand the etiology
of the LOI syndrome BWS. The goal of this paper was
to ascertain baseline allelic expression and DNA methy-
lation in control bovine concepti of imprinted genes/
regions known to be misregulated in BWS. Similar to
what has been previously reported [40,41]; we show that
KCNQ1OT1, H19, CDKN1C and PLAGL1 are imprinted
in the bovine. In addition, we confirm that the KvDMR1
and H19/IGF2 ICR are differentially methylated in the
bovine genome which is in accordance to what has been
reported in humans. Our study extends previous work
Robbins et al. Journal of Biomedical Science 2012, 19:95 Page 3 of 10
http://www.jbiomedsci.com/content/19/1/95[40,41] in that it provides fixed DNA sequence poly-
morphisms between Bos taurus indicus and Bos taurus
taurus that can be used to distinguish with certainty the
parental alleles in F1 individuals.
Methods
DNA sequence polymorphism identification
The ability to differentiate between parental alleles in an
F1 individual is fundamental when performing genomic
imprinting studies. For our studies we used two subspe-
cies of cattle (Bos taurus taurus, Bos taurus indicus),
which diverged ~620,000 years ago [42], to produce F1
individuals. Studies have shown that single nucleotide
polymorphisms (SNP) should be found every 172 base
pairs (bp) within the exon regions of genes between B. t.
taurus and B. t. indicus [43,44]. Genomic regions
sequenced included the exons of KCNQ1OT1, H19,
CDKN1C, and PLAGL1 as well as the KvDMR1 and H19/
IGF2 ICRs. Table 1 shows the subspecies-specific single
nucleotide polymorphisms (SNPs) for these regions.
Production of Bos taurus indicus x B. taurus taurus day 65
F1 concepti
All animal work was done in accordance with the Univer-
sity of Missouri Animal Care and Use Committee. The es-
trous cycles of seven B. t. taurus heifers (6 Angus, 1
Hereford) were synchronized using the 14-CIDRW-PG
(Controlled Intravaginal Drug-Releasing Device and Pros-
taglandin) estrus synchronization protocol. Briefly, CIDRs
were inserted for 14 days to suppress progesterone levels.
Sixteen days after the removal of the CIDRs, 25 mg of
prostaglandin F2 alpha (Lutalyse; dinoprost tromethamine;
Pfizer Animal Health, New York, NY) was administered
intramuscularly (i.m.). Three days after prostaglandin in-
jection, 100 mcg of gonadotropin releasing hormone was
administered i.m. (Cystorelin; gonadorelin diacetate tetra-
hydrate; Merial; Duluth, GA). Heifers were then artificially
inseminated with semen from one B. t. indicus bull
(Nelore breed; ABS CSS MR N OB 425/1 677344Table 1 DNA sequence polymorphisms used to ascertain allel
Gene/
ICR Symbol




H19 gene expression C T
KCNQ1OT1 gene expression A G
CDKN1C gene expression C T
PLAGL1 gene expression T G
H19/IGF ICR DNA methylation A G
KvDMR1 DNA methylation G, A, A in/
del between GA, C**
C**, G, G, in/
del between GA
“GCG”, G
CDKN1C DMR DNA methylation N/A N/A
PM=polymorphisms, N/A=not applicable, C**= During bisulfite conversion the C is c29NE0001 97155). Three out of the seven heifers (2
Angus, 1 Hereford) were confirmed pregnant by ultra-
sonographic examination on day 30 of gestation. Two
males and one female B. t. indicus x B. t. taurus F1 con-
cepti were collected on day 65 of gestation at the Univer-
sity of Missouri Veterinary School’s abattoir (Figure 1).
Concepti were collected on day 65 because a study by
Cezar et al. [45] determined that DNA methylation
levels were the same between a day 60 fetus and an adult
animal. The following tissues were collected: amnion,
chorioallantois, brain, tongue, heart, kidney, liver, lung,
intestines, and reproductive tract. Tissues were snap fro-
zen in liquid nitrogen and stored at −80°C until use.
RNA extraction and cDNA synthesis for parental-allelic
expression analysis
The chorioallantois, liver, brain, heart, and tongue of day
65 B. t. indicus x B. t. taurus F1 concepti were homoge-
nized with a plastic disposable pestle (Fischer Scientific;
Pittsburgh, PA) in 450μl of lysis binding buffer (4.5M
guanidine-HCl, 50mM Tris-HCl, 30% Triton X-100 (w/v),
pH 6.6). The tissue lysates were then passed through a 22
and 26 gauge needles connected to a 1ml syringe. RNA
was extracted from the tissues using a commercially avail-
able kit (High Pure RNA; Roche Applied Science; Mann-
heim, Germany) following manufacturer’s specifications.
cDNA was synthesized in a 20μl reaction using 10μl of
RNA (130 ng Total RNA) and 10μl of a master mix con-
taining: 10 mM DTT (Invitrogen; Carlsbad, CA), 1X
First Strand buffer (Invitrogen; Carlsbad, CA), 0.5 μg
random primers (Promega; Madison, WI), 1mM dNTPs
(Fischer Scientific; Pittsburgh, PA), 100 units Superscript
II reverse transcriptase (RT; Invitrogen; Carlsbad, CA),
and 20 units of Optizyme RNase Inhibitor (Fischer Sci-
entific; Pittsburgh, PA). The samples were then incu-
bated in a thermal cycler for one hour at 42°C followed
by ten minutes at 95°C. The samples were then stored in
the −20°C until further analysis. To verify the absence of




# (based on Btau-4.2)
PM location in
reference Btau 4.2
Exon 2–5 NR_003958.2 1831
Exon 1 (close to the
start of transaction)
NW_001494547.3 3146321
Exon 2–4 NW_001494547.3 2955801
Exon 6 NM_001103289.1 867
N/A NW_001494547.3 3724402
N/A NW_001494547.3 3134118, 3134110,
3134095, 3134087-
3134086, 3134072
Exon 1-Intron 2 NW_001494547.3 N/A
onverted to a T.
A B C
Figure 1 Day 65 B. t. indicus x B. t. taurus F1 concepti. The tissues from these concepti were used to determine baseline imprinted gene
expression and DNA methylation in bovine of BWS-associated loci.
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collected and cDNA prepared from several B. t. taurus
and B. t. indicus tissues to serve as restriction fragment
length polymorphism (RFLP) assay controls.Imprinted expression analysis of B. t. indicus x
B. t. taurus concepti
B. t. indicus x B. t. taurus F1 tissues were used to deter-














KvDMR1 Forward TGAGGAGTGAGTTATGAGGA (taurus)
TGAGGATTGTAGTTGTGAGGA (indicus)
Reverse CTACCACATCTACCCCAATC
CDKN1C DMR Forward GAGGACTGGGCGTTCCACAGGCCA
Reverse GCCCTTTAACGGCCAGGAGGC
Tm= Temperature in °C, bp= base pairs, [] = concentration.and PLAGL1. The PCR primers generated for expression
analyses were intron-spanning for CDKN1C and H19.
However, the primers used to amplify KCNQ1OT1 and
PLAGL1 were designed within a single exon. The possi-
bility of DNA contamination in the cDNA was assessed
by the exclusion of the Reverse Transcriptase from the
cDNA master mix in parallel samples. The conditions
used for RT-PCR were modified until a single amplicon
was observed for each primer set. The RT-PCR program










62.8 752 0.3 2.5 35
64 502 0.3 2.5 35
62 745 0.3 4 35
60 834 0.3 4 35
60 493 0.3 2.5 40
59.2 419/422 0.3 4 45
62 1108 0.4 GC Buffer II Takara 35
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(refer to Table 2), and extension (72°C for 1 min) steps
were repeated for the specified cycle number on Table 2.
The PCR programs ended with a five minute extension
at 72°C. The identity of PCR products was confirmed
by restriction enzyme digest or sequencing. No further
optimization for sensitivity was required. Primer and
PCR condition information may be found in Table 2.
RFLP was used to identify allelic expression for each gene.
The SNPs responsible for restriction site polymorphisms be-
tween B. t. taurus and B. t. indicus are shown in Table 2.
After restriction enzyme digestion the assays were
resolved by polyacrylamide gel electrophoresis (PAGE;
Table 3). For cases in which the repressed allele was
expressed the band intensity was measured by the UN-
SCAN-IT gel 5.3 alias gel analysis software (Silk Scientific;
Orem, UT) that functions as a gel band densitometer. To
be considered biallelic a sample had to have 10% or higher
expression from each parental allele [46].
DNA extraction, bisulfite mutagenesis and
COBRA procedures
DNA was extracted from day 65 B. t. indicus x B. t.
taurus F1 tissues using a phenol-chloroform extraction
procedure. Bisulfite mutagenesis was then performed
following the instructions for the Imprint DNA Modifi-
cation Kit One-Step procedure (Sigma-Aldrich; St. Louis,
MO). During the bisulfite mutagenesis procedure all
unmethylated cytosines are converted to uracils while
methylated cytosines remain cytosines. During PCR the
uracils are replaced by thymines. Primers for the bisulfite
mutagenized DNA were designed for the H19/IGF2 ICR
and the KvDMR1 (Table 2). PCR was used to amplify a
493 bp region of the H19/IGF2 ICR. The amplicon size
for the KvDMR1 was 419 bp for the taurus allele and
422 bp for the indicus allele as a result of an insertion/
deletion in the DNA sequence. For the KvDMR1, allele-
specific bisulfite primers were designed to amplify each
parental allele. The rationale for this was based on the
location of the fixed polymorphic sites between the two
subspecies of cattle as identified by Sanger sequencing.Table 3 Restriction enzymes used to determine















H19 Maternal BsiHKAI 609,143 609,35,108 18%





CDKN1C Maternal Avall 494,251 361,251,
133
10%
PLAGL1 Paternal Mlul 834 387,447 10%
PAGE= Polyacrylamide gel eclectrophoresis, bp= base pairs.In order to use the polymorphisms to determine
parental-specific methylation primers were required
within a region that is 1936 bp, 67% GC, flanked by re-
peat sequences and contains additional polymorphisms.
No single primer set was identified that amplified both
alleles. Manual design of allele-specific primers allowed
for amplification of each KvDMR1 allele separately but
in the same reaction. After bisulfite mutagenesis, ampli-
cons from differentially methylated alleles can be recog-
nized by RFLP.
Methylation status of the loci was first determined
by combined bisulfite restriction enzyme assay
(COBRA). This assay was also used to ascertain that
both the methylated and the unmethylated alleles amp-
lified equally with no amplification biased was intro-
duced during PCR. The enzymes used to digest the
originally methylated alleles were DpnII and BstUI for
the H19/IGF2 ICR and the KvDMR1, respectively. The
PCR amplicons and digested products were resolved
by 7% PAGE.
DNA Methylation analysis of the KvDMR1 and
H19/IGF2 ICR
Bisulfite-converted DNA amplicons were isolated from
agarose gels using the Wizard SV gel and PCR Clean-Up
System (Promega, Madison, WI). H19/IGF2 ICR ampli-
con was cloned using the pGEM T Easy Vector System
ligation buffer protocol (Promega). The plasmid was
transformed into chemically competent NEB 5-alpha F’Iq
E.Coli cells (New England BioLabs; Ipswich, MA)
according to the manufacturer’s instructions. The
KvDMR1 amplicon was cloned using CopyControl PCR
cloning kit with TransforMax™ EPI300™ Electrocompe-
tent E. coli cells (Epicenter Biotechnologies) according
to the manufacturer’s specifications except that all the
incubation procedures were done at room temperature.
Next, the individual clones were sequenced at the Uni-
versity of Missouri’s DNA Core using the 96-capillary
Applied Biosystems 3730 DNA Analyzer with Big Dye
Terminator.
Determination of the methylation status of
CDKN1C in bovine
In the mouse, CDKN1C’s DMR has been shown to ex-
tend from the promoter region through the second
exon. However, the homologous region is not differen-
tially methylated in humans. Many attempts (>30 primer
pairs were tested) were made to amplify the promoter of
the CDKN1C gene in bovine [NW_001494547.3;
2951474-2953864]. However, sequencing results never
coincided with the expected region on chromosome 29
although, according to the databases, the primers aligned
perfectly to the bovine CDKN1C’s promoter. In addition,
even though we were able to sequence CDKN1C’s exons








Figure 2 Allele-specific expression of B. t. indicus x B. t. taurus
F1 concepti. Shown are two examples of the RFLP assay used to
distinguish parent-specific gene expression in B. t. indicus x
B. t. taurus F1concepti. DNA sequence polymorphisms between
B. t. indicus and B. t. taurus were used as a diagnostic test to identify
the parental allele origin of the transcript. A. KCNQ1OT1
(paternally-expressed gene). Lanes = 1: B. t. taurus liver; 2: B. t. indicus
kidney, 3: B. t. indicus fat; 4: F1B heart, 5: F1B liver; 6: F1C heart. B.
H19 (maternally-expressed gene). Lanes = 1: B. t. taurus muscle; 2:
B. t. indicus fat; 3: F1A heart. M = maternal allele, P = paternal allele.
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between B. t. taurus and B. t. indicus. Therefore, we
undertook a PCR based methylation analysis to deter-
mine if the putative bovine DMR was methylated as in
mice or unmethylated as in humans.
Isoschizomers were used to test the methylation status
of CDKN1C (HpaII and MspI). These two restriction
enzymes allowed differentiation between methylated and
unmethylated CpGs. HpaII is methylation sensitive and
blocked by CpG methylation and therefore is not be able
to cut genomic DNA that is methylated at the CCGG
recognition sites. However, MspI is a methylation in-
sensitive restriction enzyme and is able to cleave both
methylated and unmethylated DNA at the CCGG recog-
nition sites.
First, genomic DNA was isolated from the kidney of
the three day 65 fetuses. The genomic DNA was divided
into five groups and treated as follows: 1) untreated
DNA, 2) DNA treated with the CpG methyltransferase
M. Sss1 (methylates all CpGs), 3) DNA treated with M.
Sss1 prior to digestion with HpaII, 4) DNA digested with
HpaII, and 5) DNA treated with MspI. All groups were
amplified by PCR. The primer pair used (Table 2) ampli-
fies a 1108 bp region encompassing exon one through
intron two which contains 19 HpaII/MspI sites.Table 4 BWS-associated imprinted gene expression in
B. t. indicus x B. t. taurus F1
Tissue KCNQ1OT1 H19 CDKN1C PLAGL1
Conceptus A (%)- expression from repressed allele
Chorioallantois Mono (2.65%) Mono (0%) Mono (0%) Mono (3.75%)
Liver Mono (6.90%) Mono (0%) Mono (0%) Mono (4.73%)
Brain Mono (6.01%) Mono (0%) Mono (0%) Mono (1.66%)
Heart N/A Mono (0%) Mono (0%) Mono (2.17%)
Tongue Mono (4.09%) Mono (0%) Mono (0%) Mono (6.39%)
Conceptus B
Chorioallantois Mono (2.33%) Mono (0%) Mono (0%) Mono (5.50%)
Liver Mono (6.17%) Mono (0%) Mono (0%) N/A
Brain Mono 6.46% Mono (0%) Mono (0%) Mono (2.63%)
Heart Mono (8.01%) Mono (0%) Mono (0%) Mono (4.59%)
Tongue Mono (7.08%) Mono (0%) Mono (0%) Mono (9.58%)
Conceptus C
Chorioallantois N/A N/A N/A N/A
Liver Mono (4.01%) Mono (0%) Mono (0%) Mono (2.40%)
Brain Mono (5.60%) Mono (0%) Mono (0%) Mono (4.77%)
Heart Mono (9.74%) Mono (0%) Mono (0%) Mono (5.74%)
Tongue Mono (1.96%) Mono (0%) Mono (0%) Mono (0%)
Imprinted Gene expression analyzed by RFLP. Mono= monoallelic expression.Results
Baseline imprinted gene expression in BWS-associated
genes in bovids
In order to determine if bovids could be used as a model
to study BWS we must first determine baseline expres-
sion of imprinted genes known to be misregulated with
BWS. Three B. t. indicus x B. t. taurus F1 concepti were
collected on day 65 of gestation (Figure 1). The brain,
tongue, heart, liver, and chorioallantois were analyzed
for imprinted gene expression of KCNQ1OT1, CDKN1C,
PLAGL1, and H19. In cattle, KCNQ1OT1, CDKN1C, and
H19 are located on chromosome 29 while PLAGL1 is
found on chromosome 9.
RFLP was the method used to determine allele-specific
imprinted gene expression using SNPs identified by our
lab (Figure 2). KCNQ1OT1, CDKN1C, PLAGL1, and
H19 showed the correct monoallelic expression in all tis-
sues analyzed (Table 4). Nonetheless, gene expression
was not detected in every tissue of each F1 conceptus
studied (Table 4). For example, the RNA of the chorioal-
lantois that belonged to B. t. indicus x B. t. taurus F1-C
appeared to be degraded because no detectable expres-
sion was observed for any RNA assay.
Several of the tissues studied had some level expres-
sion from the repressed allele of KCNQ1OT1, CDKN1C,
PLAGL1, however because this expression was not
greater than 10% they were considered to be expressingthose genes in a monoallelic manner. We amplified and
digested B. t. taurus and B. t. indicus to serve as controls
for restriction enzyme digestion patterns and to differen-
tiate between leaky expression of the repressed alleles
and incomplete restriction enzyme digestion of the
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H19 appeared complete.Baseline methylation in BWS-associated imprinting
control regions in bovids
COBRA (data not shown) and Bisulfite sequencing were
used to determine the methylation status of the H19/
IGF2 ICR (Figure 3) and the KvDMR1 (Figure 4). These
two ICRs are the two differentially methylated regions
primarily misregulated in BWS patients [9]. From our
study we were able to determine that differential methy-
lation is observed within these ICRs in control B. t. indi-
cus x B. t. taurus F1 concepti. Both the KvDMR1 and
the H19/IGF2 regions in the bovine showed differential5 kb
H19
Figure 3 Differential methylation at the H19/IGF2 ICR in bovine.
Top. The putative H19/IGF2 ICR is drawn to scale and depicted in
light purple. Arrow mark the start and direction of H190s
transcription. The region amplified by the bisulfite specific primers is
represented by a yellow box and encompasses a putative CTCF site.
Putative CTCF sites were determined using the University of Essex
CTCF searching database (http://www.essex.ac.uk/bs/molonc/binfo/
ctcfbind.htm) and are depicted by black vertical lines. From left to
right CTCF site 1(cgttaagggg – located at −4739 to −4749 bp from
H190s transcription start site). CTCF2 (ccgcgaggcggcag −4311 to
−4325 bp), CTCF3 (ccgcggggcggcgg −3882 to −3896 bp), CTCF4
(cgttaagggg −3372 to −3382 bp), CTCF5 (ccgcgaggcggcag −2944 to
−2958 bp), CTCF6 (tggacagggg −1739 to −1749 bp), CTCF7
(ccgcgaggcggcgg −1492 to −1506 bp), CTCF8 (tgttgagggg −251 to
−261 bp). Bottom. Shown is an example of bisulfite sequence data
from an F1 individual. The bisulfite converted DNA was amplified
and cloned prior to sequencing. Each line of circles represents
individual alleles. Open circles represent unmethylated CpGs and
closed circles represent methylated CpGs. Female
symbol = maternal alleles, male symbol = paternal alleles. The
position of the SNP used to differentiate between B. t. indicus
and B. t. taurus alleles is shown by an arrow.methylation between the parental alleles similar to what
has been observed in humans [47-50].
Methylation analysis of CDKN1C’s putative DMR in bovids
The PCR primers were able to amplify a region of
the correct size for the untreated genomic DNA, the
M. Sss1 treated DNA, and the M. Sss1 + HpaII treated
DNA groups. As expected, MspI digestion cleaved the
DNA thus fragmenting the template and preventing
amplification of the region (Figure 5). No amplicons
were detected for the genomic DNA treated with HpaII
suggesting at least one hypomethylated CpG in this gen-
omic region.
Discussion
In this study, we set out to determine the pattern of ex-
pression in bovids of four imprinted genes associated
with the human overgrowth syndrome Beckwith-Wiede-
mann. We analyzed gene expression and DNA methyla-
tion in embryonic and extraembryonic tissues of three
day 65 B. t. indicus x B. t. taurus F1 concepti. By using
RT-PCR and RFLP analysis we were able to determineFigure 4 Differential methylation at the KvDMR1 in bovids. Top.
Part of KCNQ1 10th intron is drawn to scale and depicted in light
purple. Arrow depicts direction of KCNQ1OT1’s transcription. The
region amplified by the bisulfite specific primers is represented by a
yellow box. Bottom. Shown is an example of bisulfite sequence data
from an F1 individual. The bisulfite converted DNA was amplified
and cloned prior to sequencing. Each line of circles represents
individual alleles. Open circles represent unmethylated CpGs and
closed circles represent methylated CpGs. Female symbol =
maternal alleles, male symbol = paternal alleles. The position of the
SNP used to differentiate between B. t. indicus and B. t. taurus alleles
is shown by arrows. The insertion/deletion “GCG” SNP (Table 2)






H N F1 H N F1 H N F1 H N F1 H N F1 - PCR
Figure 5 Methylation analysis of CDKN1C’s DMR in bovine.
Restriction enzyme analysis was used to determine the methylation
status of CDKN1C DMR in the bovine. The restriction enzymes HPAII
(blocked by CpG methylation) and MSPI (able to digest both
methylated and unmethylated CpGs) were used to determine the
methylation of CDKN1C exons 1 through intron 2. M. Sss1
(methylates all CpGs) was used as a positive control to show that
HPAII is unable to cleave methylated CpGs. Our results show that at
least one of the 19 CCGG recognition sites for HPAII was
unmethylated because there was no PCR amplification of this region
for the HPAII digested template. H = Holstein, N = Nelore, F1 =
B. t. indicus x B. t. taurus F1-C conceptus. - PCR = water PCR control
to show no DNA contamination.
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http://www.jbiomedsci.com/content/19/1/95the imprinted gene expression for KCNQ1OT1, PLAGL1,
CDKN1C, and H19. Our results showed that similar to
humans, KCNQ1OT1 and PLAGL1 are monoallelically
expressed from the paternal allele while CDKN1C and
H19 are maternally-expressed genes. The imprinted gene
expression was observed in all tissues analyzed which
included brain, heart, liver, tongue, and chorioallantois.
Another result from this study confirmed recent
observations [40] that the KvDMR1 and the H19/IGF2
ICRs are differentially methylated in cattle as has been
reported for human and mouse. Our results add to
the current knowledge because of our ability to un-
equivocally assign methylation status of these ICRs to
each parental allele based on the identified SNPs. Results
from this work suggest that the CDKN1C’s promoter is
hypomethylated in bovine as it is in human. This is in
accordance with Hori et al. [40] who has recently
reported a hypomethylated state of the aforementioned
promoter.
The imprinted genes associated with BWS have been
shown to be conserved between the human and mouse
[51-56]. However, there have been several mouse models
which have not been able to recapitulate all the diagnos-
tic clinical features associated with BWS [39,57]. Nocurrent animal models are able to fully phenocopy BWS.
This fact is important for investigators with the goal
treating BWS symptoms.
There are many reasons to propose the use of bovids as a
model to study BWS. First, LOS has several phenotypical
similarities with BWS [30,31,33,37,38]. Second, increased
IGF2 expression has been observed in day 70 LOS concepti
[32]. This is of relevance since 2–10% of BWS patients have
biallelic expression of the paternally-expressed IGF2 in
tongue and in fibroblast [58]. In BWS, IGF2’s biallelic ex-
pression is due to gain of methylation on the paternal allele
at the H19/IGF2 ICR. Third, the parent-specific expression
pattern of several imprinted genes in the mouse is not con-
served in humans (i.e. Gatm, Dcn, and IGF2r; [59-63]).
Fourth, comparative genome analyses [64,65] show that the
percent identity between the genomes of cattle and human
is 73.8% while the percent identity between the mouse and
human genomes is 66.8% [66]. In addition, pairwise align-
ments with the human genome of putative transcriptional
regulatory regions show a higher homology for cow than
for mouse (~80% vs. ~70% [66]). Fifth, as expected given
the genomic similarity between human and bovine, we
show here that there is conservation of expression and
methylation patterns at the BWS-associated loci. Sixth,
both species have a nine month gestation period. This is
relevant because the sequence of events that result in a
condition may occur at similar times during pregnancy.
Seventh, both the bovine and human gestation usually
involves one offspring. It is likely that there has been diver-
gence for growth regulation of the conceptus between litter
bearing and non-litter bearing species.
Another important similarity between humans and rumi-
nants is the adverse response of preimplantation embryos
to in vitro manipulations. For instance, children that are
conceived by the use of assisted reproductive technologies
have a higher incidence (3–9 times) of having the LOI
overgrowth syndrome BWS [23,26,48,67-70]. Likewise, a
fetal overgrowth syndrome has also been documented
in ruminants as a result of ART. In ruminants this syn-
drome is known as LOS. Since the overgrowth pheno-
type has been observed in ruminants and humans as a
result of assisted reproduction, we [71] and others [40]
have proposed that both syndromes have similar epi-
genetic etiologies. In order to determine the plausibility
of our hypothesis we need to ascertain if all BWS-
associated imprinted gene expression misregulation is
recapitulated in LOS. Ongoing studies from our labora-
tory are determining if LOS and BWS are epigenetically
similar.
Conclusion
In conclusion, our study established the imprinting sta-
tus of KCNQ1OT1, CDKN1C, PLAGL1, and H19 in bo-
vine day 65 B. t. indicus x B. t. taurus F1concepti and
Robbins et al. Journal of Biomedical Science 2012, 19:95 Page 9 of 10
http://www.jbiomedsci.com/content/19/1/95found that imprinting was conserved with humans.
These genes are associated with the human overgrowth
and loss-of-imprinting syndrome BWS. We have also
determined that the ICRs primarily affected in BWS,
namely KVDMR1 and H19/IGF2, are differentially
methylated in bovids as in humans. Currently no animal
models are able to fully recapitulate BWS. Our results
suggest that bovids may be able to serve as an appropri-
ate animal model for studying BWS.
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